University of Texas Health Science Center at San Antonio

The University of Texas Health Science Center at San Antonio (UTHSCSA) is an institute of health science education and research, located in the South Texas Medical Center. UTHSCSA is the largest health sciences university in South Texas. Located in the South Texas Medical Center, it serves San Antonio and all of the 50,000 square miles (130,000 km) area of central and south Texas. It extends to campuses in the metropolitan border communities of Laredo and the Rio Grande Valley. With 24,000 graduates, more than 3,000 students a year train in an environment that involves more than 100 affiliated hospitals, clinics and health care facilities in South Texas. The university offers over 65 degrees, the majority of them being graduate and professional degrees, in the biomedical and health sciences fields. UTHSCSA is home to the Cancer Therapy & Research Center (CTRC) - a major National Cancer Institute supported Center. The CTRC's Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world.

Address
7703 Floyd Curl Dr, San Antonio, Texas, United States of America 78229
Website
http://www.uthscsa.edu/
Wikipedia
http://en.wikipedia.org/wiki/University_of_Texas_Health_Science_Center_at_San_Antonio

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Novel therapy studied for inherited breast cancer

UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive ...

Genetics

APOE variants' effect on mortality studied in 38,000

A new study of 38,537 persons of European ancestry suggests that a rare variation of a gene called APOE may be protective and prolong life, in sharp contrast to a more widely studied APOE variant that increases risk of death.

Cardiology

New treatment option shown for heart failure fluid overload

Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive approach relieved fluid overload safely and ...

Neuroscience

Novel therapy administered after TBI prevents brain damage

An experimental treatment given to mice after a traumatic brain injury (TBI) reduced damage almost to the levels of mice that never had a TBI, researchers at UT Health San Antonio reported. The study was published July 4 ...

Diseases, Conditions, Syndromes

Largest study of CTE finds it in 6% of subjects

Nearly 6% of athletes and non-athletes were found to have the neurodegenerative disorder chronic traumatic encephalopathy (CTE) in the largest, and broadest, study conducted of the disease to date. The findings were published ...

Cardiology

Team studies smarter automatic defibrillator

Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators (AICDs) that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival ...

Oncology & Cancer

Do all chemotherapies have equal long-term heart risk?

In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs ...

page 1 from 11